An2 Therapeutics Stock Price History
ANTX Stock | USD 1.39 0.05 3.73% |
If you're considering investing in AN2 Stock, it is important to understand the factors that can impact its price. As of today, the current price of AN2 Therapeutics stands at 1.39, as last reported on the 25th of November, with the highest price reaching 1.45 and the lowest price hitting 1.35 during the day. AN2 Therapeutics appears to be slightly risky, given 3 months investment horizon. AN2 Therapeutics retains Efficiency (Sharpe Ratio) of 0.0749, which signifies that the company had a 0.0749% return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for AN2 Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of AN2 Therapeutics' Standard Deviation of 3.62, market risk adjusted performance of 0.476, and Coefficient Of Variation of 1047.82 to double-check if our risk estimates are consistent with your expectations.
At this time, AN2 Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 292.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 21.8 M in 2024. . Price Earnings Ratio is likely to drop to -7.84 in 2024. Price Book Value Ratio is likely to drop to 3.68 in 2024. AN2 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
AN2 |
Sharpe Ratio = 0.0749
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ANTX | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.63 actual daily | 32 68% of assets are more volatile |
Expected Return
0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average AN2 Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AN2 Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.4567 | Book Value 4.193 | Enterprise Value -55.2 M | Enterprise Value Ebitda (2.11) | Shares Float 11.4 M |
AN2 Therapeutics Stock Price History Chart
There are several ways to analyze AN2 Stock price data. The simplest method is using a basic AN2 candlestick price chart, which shows AN2 Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 25, 2024 | 1.39 |
Lowest Price | November 14, 2024 | 1.0 |
AN2 Therapeutics November 25, 2024 Stock Price Synopsis
Various analyses of AN2 Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AN2 Stock. It can be used to describe the percentage change in the price of AN2 Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AN2 Stock.AN2 Therapeutics Price Daily Balance Of Power | 0.50 | |
AN2 Therapeutics Price Action Indicator | 0.01 | |
AN2 Therapeutics Price Rate Of Daily Change | 1.04 | |
AN2 Therapeutics Accumulation Distribution | 33,430 |
AN2 Therapeutics November 25, 2024 Stock Price Analysis
AN2 Stock Price History Data
The price series of AN2 Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 0.34 with a coefficient of variation of 5.52. The prices are distributed with arithmetic mean of 1.07. The median price for the last 90 days is 1.06. The company issued dividends on 2018-01-11.Open | High | Low | Close | Volume | ||
11/25/2024 | 1.35 | 1.45 | 1.35 | 1.39 | 484,742 | |
11/22/2024 | 1.26 | 1.42 | 1.26 | 1.34 | 1,250,070 | |
11/21/2024 | 1.30 | 1.46 | 1.20 | 1.23 | 3,754,789 | |
11/20/2024 | 1.07 | 1.33 | 1.07 | 1.30 | 5,552,146 | |
11/19/2024 | 1.03 | 1.11 | 1.00 | 1.06 | 2,079,114 | |
11/18/2024 | 1.00 | 1.03 | 0.98 | 1.00 | 726,207 | |
11/15/2024 | 1.00 | 1.04 | 0.99 | 1.00 | 1,247,439 | |
11/14/2024 | 1.03 | 1.03 | 0.99 | 1.00 | 697,979 | |
11/13/2024 | 1.06 | 1.07 | 0.99 | 1.01 | 1,318,729 | |
11/12/2024 | 1.08 | 1.11 | 1.05 | 1.06 | 475,458 | |
11/11/2024 | 1.11 | 1.12 | 1.08 | 1.09 | 1,106,916 | |
11/08/2024 | 1.11 | 1.12 | 1.09 | 1.10 | 868,018 | |
11/07/2024 | 1.10 | 1.11 | 1.10 | 1.10 | 51,895 | |
11/06/2024 | 1.10 | 1.11 | 1.09 | 1.10 | 105,502 | |
11/05/2024 | 1.09 | 1.10 | 1.08 | 1.09 | 114,641 | |
11/04/2024 | 1.08 | 1.09 | 1.07 | 1.08 | 138,410 | |
11/01/2024 | 1.09 | 1.09 | 1.08 | 1.08 | 132,451 | |
10/31/2024 | 1.08 | 1.10 | 1.08 | 1.08 | 118,955 | |
10/30/2024 | 1.12 | 1.12 | 1.08 | 1.09 | 138,179 | |
10/29/2024 | 1.10 | 1.14 | 1.09 | 1.11 | 256,467 | |
10/28/2024 | 1.09 | 1.12 | 1.07 | 1.10 | 249,026 | |
10/25/2024 | 1.07 | 1.08 | 1.06 | 1.07 | 59,860 | |
10/24/2024 | 1.09 | 1.09 | 1.07 | 1.07 | 97,763 | |
10/23/2024 | 1.08 | 1.09 | 1.06 | 1.08 | 133,466 | |
10/22/2024 | 1.07 | 1.10 | 1.06 | 1.08 | 178,807 | |
10/21/2024 | 1.06 | 1.12 | 1.06 | 1.08 | 631,069 | |
10/18/2024 | 1.03 | 1.07 | 1.03 | 1.05 | 192,399 | |
10/17/2024 | 1.07 | 1.07 | 1.03 | 1.03 | 307,515 | |
10/16/2024 | 1.05 | 1.08 | 1.04 | 1.06 | 247,992 | |
10/15/2024 | 1.03 | 1.05 | 1.03 | 1.05 | 62,220 | |
10/14/2024 | 1.06 | 1.06 | 1.03 | 1.03 | 60,915 | |
10/11/2024 | 1.03 | 1.07 | 1.03 | 1.05 | 140,605 | |
10/10/2024 | 1.04 | 1.05 | 1.03 | 1.04 | 34,901 | |
10/09/2024 | 1.05 | 1.06 | 1.03 | 1.04 | 102,610 | |
10/08/2024 | 1.04 | 1.06 | 1.03 | 1.04 | 159,065 | |
10/07/2024 | 1.06 | 1.07 | 1.04 | 1.04 | 101,968 | |
10/04/2024 | 1.04 | 1.08 | 1.03 | 1.07 | 196,255 | |
10/03/2024 | 1.05 | 1.07 | 1.03 | 1.04 | 126,223 | |
10/02/2024 | 1.03 | 1.06 | 1.03 | 1.05 | 45,707 | |
10/01/2024 | 1.06 | 1.09 | 1.03 | 1.05 | 116,610 | |
09/30/2024 | 1.08 | 1.08 | 1.06 | 1.07 | 135,525 | |
09/27/2024 | 1.06 | 1.09 | 1.06 | 1.06 | 175,519 | |
09/26/2024 | 1.06 | 1.07 | 1.03 | 1.06 | 197,136 | |
09/25/2024 | 1.06 | 1.06 | 1.03 | 1.05 | 262,504 | |
09/24/2024 | 1.05 | 1.09 | 1.04 | 1.04 | 360,449 | |
09/23/2024 | 1.06 | 1.08 | 1.04 | 1.04 | 60,466 | |
09/20/2024 | 1.08 | 1.08 | 1.05 | 1.05 | 311,847 | |
09/19/2024 | 1.07 | 1.08 | 1.05 | 1.08 | 384,418 | |
09/18/2024 | 1.07 | 1.09 | 1.05 | 1.06 | 252,671 | |
09/17/2024 | 1.05 | 1.07 | 1.05 | 1.06 | 170,967 | |
09/16/2024 | 1.05 | 1.07 | 1.04 | 1.05 | 165,462 | |
09/13/2024 | 1.03 | 1.06 | 1.02 | 1.04 | 219,275 | |
09/12/2024 | 1.05 | 1.06 | 1.01 | 1.04 | 159,873 | |
09/11/2024 | 1.04 | 1.06 | 1.03 | 1.04 | 148,986 | |
09/10/2024 | 1.05 | 1.06 | 1.03 | 1.03 | 113,673 | |
09/09/2024 | 1.01 | 1.08 | 1.01 | 1.04 | 245,912 | |
09/06/2024 | 1.04 | 1.05 | 1.01 | 1.02 | 429,211 | |
09/05/2024 | 1.04 | 1.06 | 1.01 | 1.03 | 702,389 | |
09/04/2024 | 1.08 | 1.10 | 1.03 | 1.03 | 311,968 | |
09/03/2024 | 1.15 | 1.17 | 1.07 | 1.10 | 279,425 | |
08/30/2024 | 1.13 | 1.16 | 1.13 | 1.13 | 197,565 |
About AN2 Therapeutics Stock history
AN2 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AN2 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AN2 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AN2 Therapeutics stock prices may prove useful in developing a viable investing in AN2 Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 23.6 M | 21.8 M | |
Net Loss | -38.5 M | -40.4 M |
AN2 Therapeutics Quarterly Net Working Capital |
|
AN2 Therapeutics Stock Technical Analysis
AN2 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
All Next | Launch Module |
AN2 Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AN2 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AN2 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AN2 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0811 | |||
Jensen Alpha | 0.2483 | |||
Total Risk Alpha | (0.23) | |||
Sortino Ratio | 0.0758 | |||
Treynor Ratio | 0.466 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for AN2 Stock Analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.